Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) - 1 Jul 2011

Frullanti Elisa, Berking Carola, Harbeck Nadia, Jézéquel Pascal, Haugen Aage, Mawrin Christian, Parise Orlando, Sasaki Hidefumi, Tsuchiya Norihiko, Dragani Tommaso A

Abstract excerpt

Fibroblast growth factor receptor 4 (FGFR4) contains a Gly388Arg functional polymorphism (rs351855) that has shown contrasting results in association studies. In this study, we assessed the association between the FGFR4 Gly388Arg polymorphism and cancer prognosis. Meta-analysis and pooled analysis of 6817 and 2537 cancer cases, respectively, were carried out by nodal status and overall survival. The study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FGFR4 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Neoplasms

Share to Polymorphism, Genetic

Share to Prognosis

Share to Receptor, Fibroblast Growth Factor, Type 4

Source

Identifiers

PMID: 21412156
DOI: 10.1097/CEJ.0b013e3283457274

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.PMID 21412156Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Semantic proximity Read ↗

FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Semantic proximity Read ↗

Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancer.Semantic proximity Read ↗

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.Semantic proximity Read ↗

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer.Semantic proximity Read ↗

The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.Semantic proximity Read ↗

FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.